FDA to provide guidances on how to appeal rejected applications -- CDER'S Woodcock.
This article was originally published in The Tan Sheet
Executive Summary
FDA TO INCLUDE APPEALS GUIDANCES WITH REJECTED DRUG APPLICATIONS, Center for Drug Evaluation & Research Director Janet Wood-cock, MD, reported at a Nov. 9 Food & Drug Law Institute/FDA-sponsored video conference. Responding to industry complaints that companies do not "know how to appeal" agency decisions, CDER will append to rejected NDAs and INDs "some general information on how to appeal and what your rights are," Woodcock explained.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning